$COLL
COLLEGIUM PHARMACEUTICAL, INC

2024 Q2 Form 10-Q Financial Statement

#000155837024007601 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $145.3M $144.9M
YoY Change 7.18% 0.11%
Cost Of Revenue $54.47M $53.47M
YoY Change -11.75% -20.63%
Gross Profit $90.81M $91.46M
YoY Change 23.0% 18.16%
Gross Profit Margin 62.51% 63.11%
Selling, General & Admin $43.34M $41.98M
YoY Change 13.46% -20.45%
% of Gross Profit 47.72% 45.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.47M $917.0K
YoY Change -7.54% 12.24%
% of Gross Profit 39.06% 1.0%
Operating Expenses $43.34M $41.98M
YoY Change 13.46% -20.45%
Operating Profit $47.47M $49.47M
YoY Change 33.22% 100.89%
Interest Expense -$11.19M $17.34M
YoY Change -37.26% -19.08%
% of Operating Profit -23.57% 35.05%
Other Income/Expense, Net
YoY Change
Pretax Income $29.10M $36.62M
YoY Change 63.49% -308.59%
Income Tax $9.491M $8.909M
% Of Pretax Income 32.62% 24.33%
Net Earnings $19.61M $27.71M
YoY Change 50.73% -259.03%
Net Earnings / Revenue 13.5% 19.12%
Basic Earnings Per Share $0.60 $0.86
Diluted Earnings Per Share $0.52 $0.71
COMMON SHARES
Basic Shares Outstanding 32.72M 31.96M
Diluted Shares Outstanding 40.38M 41.44M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $272.6M $318.0M
YoY Change -16.24% 18.02%
Cash & Equivalents $172.9M $228.6M
Short-Term Investments $99.73M $89.44M
Other Short-Term Assets $26.85M $15.24M
YoY Change 46.55% -9.26%
Inventory $27.86M $31.28M
Prepaid Expenses
Receivables $183.9M $174.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $510.2M $539.3M
YoY Change -5.04% 8.22%
LONG-TERM ASSETS
Property, Plant & Equipment $14.98M $15.46M
YoY Change -38.85% -18.13%
Goodwill $133.9M $133.9M
YoY Change 0.0% 0.0%
Intangibles $352.7M $387.2M
YoY Change -28.4% -26.95%
Long-Term Investments
YoY Change
Other Assets $858.0K $954.0K
YoY Change -96.66% 996.55%
Total Long-Term Assets $543.2M $575.0M
YoY Change -19.72% -19.69%
TOTAL ASSETS
Total Short-Term Assets $510.2M $539.3M
Total Long-Term Assets $543.2M $575.0M
Total Assets $1.053B $1.114B
YoY Change -13.22% -8.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.412M $6.020M
YoY Change -0.33% 101.2%
Accrued Expenses $38.73M $38.19M
YoY Change -84.18% 56.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $183.3M $183.3M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $461.7M $446.4M
YoY Change 6.13% 8.17%
LONG-TERM LIABILITIES
Long-Term Debt $369.5M $439.8M
YoY Change -35.34% -28.49%
Other Long-Term Liabilities $5.593M $5.860M
YoY Change -15.64% -14.74%
Total Long-Term Liabilities $375.1M $445.6M
YoY Change -35.11% -28.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $461.7M $446.4M
Total Long-Term Liabilities $375.1M $445.6M
Total Liabilities $836.8M $892.1M
YoY Change -17.4% -13.77%
SHAREHOLDERS EQUITY
Retained Earnings -$185.9M -$205.5M
YoY Change -34.96% -31.23%
Common Stock $40.00K $39.00K
YoY Change 5.26% 2.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $216.6M $222.2M
YoY Change
Total Liabilities & Shareholders Equity $1.053B $1.114B
YoY Change -13.22% -8.24%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $19.61M $27.71M
YoY Change 50.73% -259.03%
Depreciation, Depletion And Amortization $35.47M $917.0K
YoY Change -7.54% 12.24%
Cash From Operating Activities $67.40M $61.94M
YoY Change -32.41% 123.83%
INVESTING ACTIVITIES
Capital Expenditures $270.0K $568.0K
YoY Change 382.14% 222.73%
Acquisitions
YoY Change
Other Investing Activities -$8.636M -$17.56M
YoY Change -79.27%
Cash From Investing Activities -$8.906M -$18.13M
YoY Change -78.65% 10200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -114.2M -54.15M
YoY Change 152.47% -179.28%
NET CHANGE
Cash From Operating Activities 67.40M 61.94M
Cash From Investing Activities -8.906M -18.13M
Cash From Financing Activities -114.2M -54.15M
Net Change In Cash -55.72M -10.34M
YoY Change -536.34% -110.79%
FREE CASH FLOW
Cash From Operating Activities $67.40M $61.94M
Capital Expenditures $270.0K $568.0K
Free Cash Flow $67.13M $61.37M
YoY Change -32.65% 123.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 coll Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2024Q1 coll Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2023Q1 coll Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2024Q1 coll Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2023Q1 coll Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2024Q1 coll Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2024Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2024Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2023Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001267565
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-37372
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Collegium Pharmaceutical, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0416362
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Technology Center Drive
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Stoughton
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02072
CY2024Q1 dei City Area Code
CityAreaCode
781
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
713-3699
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2024Q1 dei Trading Symbol
TradingSymbol
COLL
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32715322
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228610000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238947000
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
89438000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
71601000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
174693000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
179525000
CY2024Q1 us-gaap Inventory Net
InventoryNet
31276000
CY2023Q4 us-gaap Inventory Net
InventoryNet
32332000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15243000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15195000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
539260000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
537600000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15457000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15983000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5813000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6029000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
387191000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
421708000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1047000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1047000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
30671000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
26259000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
954000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
825000
CY2024Q1 us-gaap Goodwill
Goodwill
133857000
CY2023Q4 us-gaap Goodwill
Goodwill
133857000
CY2024Q1 us-gaap Assets
Assets
1114250000
CY2023Q4 us-gaap Assets
Assets
1143308000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6020000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8692000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38190000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37571000
CY2024Q1 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
217880000
CY2023Q4 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
227331000
CY2024Q1 us-gaap Loans Payable Current
LoansPayableCurrent
183333000
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
183333000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1013000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
988000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
446436000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
457915000
CY2024Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
177360000
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
221713000
CY2024Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
262425000
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
262125000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5860000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6124000
CY2024Q1 us-gaap Liabilities
Liabilities
892081000
CY2023Q4 us-gaap Liabilities
Liabilities
947877000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39029639
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32705747
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38192441
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31868549
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
39000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
38000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
565111000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
565949000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6323892
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6323892
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
137381000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
137381000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-124000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
14000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-205476000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-233189000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
222169000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
195431000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1114250000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1143308000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144923000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144767000
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
18950000
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
29899000
CY2024Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
34517000
CY2023Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
37466000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
53467000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
67365000
CY2024Q1 us-gaap Gross Profit
GrossProfit
91456000
CY2023Q1 us-gaap Gross Profit
GrossProfit
77402000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41982000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52775000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
41982000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
52775000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
49474000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
24627000
CY2024Q1 us-gaap Interest Expense
InterestExpense
17339000
CY2023Q1 us-gaap Interest Expense
InterestExpense
21427000
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
4487000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
2747000
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23504000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36622000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17557000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8909000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-131000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
27713000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17426000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32326589
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34319291
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41438466
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34319291
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
27713000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17426000
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-138000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-138000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27575000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17426000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
27713000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-17426000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34517000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37466000
CY2024Q1 us-gaap Depreciation
Depreciation
917000
CY2023Q1 us-gaap Depreciation
Depreciation
817000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4412000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-46000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7475000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6035000
CY2024Q1 coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
-22000
CY2023Q1 coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
-105000
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1780000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2287000
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23504000
CY2024Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
415000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4832000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3993000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1056000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13606000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
177000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
238000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2536000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-502000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
660000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12131000
CY2024Q1 coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-9451000
CY2023Q1 coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-29589000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
61937000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27671000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
568000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176000
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
39110000
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
21550000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18128000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-176000
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
356000
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
169000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4205000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3848000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12874000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7736000
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
45833000
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
25000000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5846000
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
235654000
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
138638000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54146000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68297000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10337000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
95792000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
239994000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176235000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229657000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272027000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228610000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
269480000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1047000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229657000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272027000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
17468000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
19499000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
173000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
743000
CY2023Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
434000
CY2024Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2024Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2024Q1 coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
CY2024Q1 coll Returns Policy Threshold Product Return Period Prior To Expiration
ReturnsPolicyThresholdProductReturnPeriodPriorToExpiration
P6M
CY2024Q1 coll Returns Policy Threshold Product Return Period After Expiration
ReturnsPolicyThresholdProductReturnPeriodAfterExpiration
P12M
CY2024Q1 coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144923000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
144767000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
27713000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17426000
CY2024Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1622000
CY2024Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
29335000
CY2023Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-17426000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32326589
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34319291
CY2024Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
7509104
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41438466
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34319291
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2023Q1 coll Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2024Q1 coll Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
159210000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
153629000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
89438000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
76330000
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
89562000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
10000
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
134000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
89438000
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
76316000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
59000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
45000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
76330000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
60015000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
61672000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
29423000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
14658000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
89438000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
76330000
CY2024Q1 coll Sale Of Marketable Securities
SaleOfMarketableSecurities
0
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
9265000
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10384000
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
8706000
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6740000
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13305000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15208000
CY2024Q1 us-gaap Inventory Net
InventoryNet
31276000
CY2023Q4 us-gaap Inventory Net
InventoryNet
32332000
CY2024Q1 us-gaap Goodwill
Goodwill
133857000
CY2023Q4 us-gaap Goodwill
Goodwill
133857000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
951170000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
563979000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
387191000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
951170000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
529462000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
421708000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34517000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37466000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
103545000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
138062000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
110370000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
7285000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7285000
CY2024Q1 coll Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
20644000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
387191000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
14077000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2136000
CY2024Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7141000
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
14198000
CY2024Q1 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
5525000
CY2023Q4 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
5013000
CY2024Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1754000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1198000
CY2024Q1 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
1519000
CY2023Q4 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
1375000
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1430000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
700000
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1406000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4987000
CY2024Q1 coll Accrued Payables For Inventory Current
AccruedPayablesForInventoryCurrent
1338000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
968000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1511000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
944000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2853000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2088000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3600000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38190000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37571000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
195431000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4205000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
356000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2024Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-12874000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7475000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-138000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
27713000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
222169000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
194842000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3848000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
169000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2023Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-7736000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6035000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-17426000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
179733000
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
922775
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7475000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6035000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
72231000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8909000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-131000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2023Q1 coll Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Extinguishment Cost Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtExtinguishmentCostAmount
21238000

Files In Submission

Name View Source Status
0001558370-24-007601-index-headers.html Edgar Link pending
0001558370-24-007601-index.html Edgar Link pending
0001558370-24-007601.txt Edgar Link pending
0001558370-24-007601-xbrl.zip Edgar Link pending
coll-20240331.xsd Edgar Link pending
coll-20240331x10q.htm Edgar Link pending
coll-20240331x10q001.jpg Edgar Link pending
coll-20240331xex31d1.htm Edgar Link pending
coll-20240331xex31d2.htm Edgar Link pending
coll-20240331xex32d1.htm Edgar Link pending
coll-20240331xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
coll-20240331_cal.xml Edgar Link unprocessable
coll-20240331_def.xml Edgar Link unprocessable
coll-20240331_pre.xml Edgar Link unprocessable
coll-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
coll-20240331x10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending